Christopher K Daugherty1, Fay J Hlubocky. 1. Department of Medicine, Section of Hematology/Oncology, MacLean Center for Clinical Medical Ethics, and Cancer Research Center, The University of Chicago, Chicago, IL 60637, USA. cdaugher@medicine.bsd.uchicago.edu
Abstract
PURPOSE: Little is known about how physicians discuss prognosis with terminally ill cancer patients. Thus, we sought to obtain cancer physicians' self-reports of their prognosis communication practices. METHODS: A survey seeking self-reports regarding prognosis communication with their terminally ill cancer patients was mailed to a systematic sample of medical oncologists in the United States. RESULTS: Of 1,137 physicians, 729 completed and returned surveys (64% response rate). Median age of respondents was 51 years (range, 33 to 80 years); 82% were men. Respondents had practiced cancer care for a median of 18 years (range, 1.5 to 50 years) and reported seeing a median of 60 patients per week (range, 0 to 250 patients per week). Although 98% said their usual practice is to tell terminally ill patients that they will die, 48% specifically described communicating terminal prognoses to patients only when specific preferences for prognosis information were expressed. Forty-three percent said they always or usually communicate a medical estimate of time as to when death is likely to occur, and 57% reported sometimes, rarely, or never giving a time frame. Seventy-three percent said prognosis communication education was either absent or inadequate during their training, and 96% believed it should be part of cancer care training. CONCLUSION: Medical oncologists report routinely informing their terminally ill patients that they will die. However, they are divided in describing themselves as either always discussing a terminal prognosis or doing so if it is consistent with their patients' preferences for prognostic information. Most medical oncologists say they do not routinely communicate an estimated survival time to their patients.
PURPOSE: Little is known about how physicians discuss prognosis with terminally ill cancerpatients. Thus, we sought to obtain cancer physicians' self-reports of their prognosis communication practices. METHODS: A survey seeking self-reports regarding prognosis communication with their terminally ill cancerpatients was mailed to a systematic sample of medical oncologists in the United States. RESULTS: Of 1,137 physicians, 729 completed and returned surveys (64% response rate). Median age of respondents was 51 years (range, 33 to 80 years); 82% were men. Respondents had practiced cancer care for a median of 18 years (range, 1.5 to 50 years) and reported seeing a median of 60 patients per week (range, 0 to 250 patients per week). Although 98% said their usual practice is to tell terminally ill patients that they will die, 48% specifically described communicating terminal prognoses to patients only when specific preferences for prognosis information were expressed. Forty-three percent said they always or usually communicate a medical estimate of time as to when death is likely to occur, and 57% reported sometimes, rarely, or never giving a time frame. Seventy-three percent said prognosis communication education was either absent or inadequate during their training, and 96% believed it should be part of cancer care training. CONCLUSION: Medical oncologists report routinely informing their terminally ill patients that they will die. However, they are divided in describing themselves as either always discussing a terminal prognosis or doing so if it is consistent with their patients' preferences for prognostic information. Most medical oncologists say they do not routinely communicate an estimated survival time to their patients.
Authors: D P Sulmasy; P B Terry; C S Weisman; D J Miller; R Y Stallings; M A Vettese; K B Haller Journal: Ann Intern Med Date: 1998-04-15 Impact factor: 25.391
Authors: Giselle K Perez; John M Salsman; Kaitlyn Fladeboe; Anne C Kirchhoff; Elyse R Park; Abby R Rosenberg Journal: Am Soc Clin Oncol Educ Book Date: 2020-03
Authors: Sarguni Singh; Dagoberto Cortez; Douglas Maynard; James F Cleary; Lori DuBenske; Toby C Campbell Journal: J Oncol Pract Date: 2017-01-17 Impact factor: 3.840
Authors: Sarah A M Hallen; Norbert A M Hootsmans; Laura Blaisdell; Caitlin M Gutheil; Paul K J Han Journal: Health Expect Date: 2014-05-12 Impact factor: 3.377
Authors: Eugene Suh; Christopher K Daugherty; Kristen Wroblewski; Hannah Lee; Mackenzie L Kigin; Kenneth A Rasinski; Jennifer S Ford; Emily S Tonorezos; Paul C Nathan; Kevin C Oeffinger; Tara O Henderson Journal: Ann Intern Med Date: 2014-01-07 Impact factor: 25.391
Authors: Paul Craig Nathan; Christopher Keller Daugherty; Kristen Elizabeth Wroblewski; Mackenzie Louise Kigin; Tom Vernon Stewart; Fay Jarmila Hlubocky; Eva Grunfeld; Marie Elisabeth Del Giudice; Leigh-Anne Evelyn Ward; James Mahlon Galliher; Kevin Charles Oeffinger; Tara Olive Henderson Journal: J Cancer Surviv Date: 2013-03-08 Impact factor: 4.442